Tapani Luukkainen

No ORCID on file · 5 papers in corpus · active 1982-2001

Study types

  • article 4
  • review 1

Condition tags

  • dysmenorrhea 1
  • mesh:D004715 1
  • endometriosis 1
review 2001
Therapeutic Use of the LNG IUS, and Counseling
Seminars in reproductive medicine ·doi:10.1055/s-2001-18644

The intrauterine release of levonorgestrel (LNG) alters the function of the endometrium. This phenomenon offers special health benefits for users and a manner of local intrauterine therapy. In this review we discuss use of LNG-releasing int…

article 1995
Uterus and endometrium: The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation
·doi:10.1093/oxfordjournals.humrep.a136305

To evaluate non-invasively the role of levonorgestrel releasing devices in direct contact with the endometrium on menstrual spotting and endometrium inactivation, we inserted levonorgestrel releasing devices (20 micrograms/24 h) either into…

article 1993
Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception
·doi:10.1016/s0015-0282(16)56209-8
article 1988
Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.

Healthy, regularly menstruating women were treated with the antiprogesterone RU 486, Mifepristone (Roussel-Uclaf, Romainville, France) during the follicular phase of the cycle. Three women were given 25 mg of RU 486 on days 1 to 14 of the c…

article 1982
TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD
·doi:10.1111/j.1365-2265.1982.tb01625.x

Thirteen women who were scheduled for hysterectomy volunteered for the study. Nine women had a levonorgestrel-releasing intrauterine contraceptive device inserted between 36 and 49 days prior to surgery and four women were on oral levonorge…